Seres Therapeutics, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2017 | $3.0M | $-25.9M | $-25.5M |
| Jun 2017 | $3.0M | $-28.4M | $-28.0M |
| Sep 2017 | $23.0M | $-7.3M | $-6.9M |
| Dec 2017 | — | $-29.8M | $-29.0M |
| Mar 2018 | $4.0M | $-28.3M | $-27.9M |
| Jun 2018 | $4.6M | $-28.1M | $-27.8M |
| Sep 2018 | $9.1M | $-22.2M | $-21.9M |
| Dec 2018 | — | $-21.7M | $-21.3M |
| Mar 2019 | $7.3M | $-24.6M | $-24.3M |
| Jun 2019 | $12.5M | $-10.9M | $-10.8M |
| Sep 2019 | $7.0M | $-17.2M | $-16.4M |
| Dec 2019 | — | $-19.2M | $-18.8M |
| Mar 2020 | $8.2M | $-19.7M | $-19.9M |
| Jun 2020 | $6.0M | $-20.5M | $-20.7M |
| Sep 2020 | $1.4M | $-30.0M | $-30.3M |
| Mar 2021 | $5.7M | $-35.3M | $-35.5M |
| Jun 2021 | $5.3M | $-48.1M | $-48.3M |
| Sep 2021 | $126.7M | $68.4M | $68.2M |
| Mar 2022 | $1.5M | $-55.8M | $-56.6M |
| Jun 2022 | $1.2M | $-63.3M | $-64.7M |
| Sep 2022 | $3.4M | $-59.1M | $-60.0M |
| Mar 2023 | $-522.0K | $-70.6M | $-71.2M |
| Jun 2023 | $126.5M | $49.5M | $46.6M |
| Sep 2023 | $310.0K | $-44.6M | $-47.9M |
| Mar 2024 | $0 | $-34.4M | $-40.1M |
| Jun 2024 | $0 | $-28.9M | $-32.9M |
| Sep 2024 | $0 | $-29.2M | $88.8M |
| Mar 2025 | $0 | $-27.2M | $32.7M |
| Jun 2025 | $0 | $-24.9M | $-19.9M |
| Sep 2025 | $351.0K | $-22.5M | $8.2M |
| Mar 2026 | $358.0K | $-20.9M | $-19.9M |
| Jun 2026 | $736.0K | $-21.3M | $4.6M |